- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
10
10 companies
WuXi XDC Cayman
Market Cap: HK$72.5b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$59.55
7D
-5.7%
1Y
66.8%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$32.1b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$54.65
7D
4.5%
1Y
356.2%
RemeGen
Market Cap: HK$53.0b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$85.30
7D
5.9%
1Y
379.2%
CanSino Biologics
Market Cap: HK$13.2b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$33.94
7D
-4.3%
1Y
-9.5%
Innovent Biologics
Market Cap: HK$136.1b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$83.30
7D
-2.1%
1Y
107.2%
Consun Pharmaceutical Group
Market Cap: HK$14.3b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.28
7D
-9.6%
1Y
105.6%
JBM (Healthcare)
Market Cap: HK$2.2b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.72
7D
-2.2%
1Y
50.3%
Essex Bio-Technology
Market Cap: HK$2.3b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.03
7D
-4.0%
1Y
39.0%
Luye Pharma Group
Market Cap: HK$9.8b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.53
7D
-2.3%
1Y
6.3%
Simcere Pharmaceutical Group
Market Cap: HK$29.8b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.82
7D
-4.7%
1Y
48.1%